LOSARTAN POTASSIUM | N218772 | SCIENTURE LLC
| Trial | Phase | Status | Sponsor | Enrollment | Dates |
|---|---|---|---|---|---|
| Phase 2 | Active | Colin D. Weekes, M.D., PhD | 70 | 2022-03-21 → 2026-12-31 | |
| Phase 2 | Active | Massachusetts General Hospital | 30 | 2011-03-08 → 2026-12 | |
| Phase 2 | Active | Massachusetts General Hospital | 168 | 2018-08-10 → 2027-04 | |
| Phase 4 | By Invitation | Baylor Research Institute | 64 | 2026-04-08 → 2029-03-31 | |
| Phase 1/2 | Not Yet Recruiting | BreakBio Corp | 10 | 2026-09 → 2030-09 | |
| Phase 2/3 | Not Yet Recruiting | Martin Blomberg Jensen | 100 | 2026-09 → 2029-04 | |
| Phase 1 | Not Yet Recruiting | Huons Co., Ltd. | 30 | 2026-10 → 2027-02 | |
| Phase 2 | Not Yet Recruiting | Massachusetts General Hospital | 27 | 2027-02 → 2028-12-30 | |
| N/A | Not Yet Recruiting | Hospital das Clínicas de Ribeirão Preto | 60 | 2026-08-02 → 2027-05-15 | |
| Phase 1/2 | Not Yet Recruiting | BreakBio Corp | 10 | 2026-09 → 2030-09 |
Source: ClinicalTrials.gov. Trials matched by ingredient name.
Lowest Price
$434.04
Highest Price
$434.04
FSS NDCs
1
Big4 NDCs
0
| Description | Price | Type | Vendor | Contract End |
|---|---|---|---|---|
| 83245-0053-06ARBLI 10MG/ML SUSP,ORAL | $434.04 | FSS | Scienture, LLC | 05/14/2026 |
Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.
27 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Feb 19, 2026 | SUPPL -2 | View Letter (PDF) |
| Mar 17, 2025 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.